Depression and apathy: examining an overlooked dimension

Apathy is a significant yet frequently overlooked aspect of Major Depressive Disorder (MDD), often confused with anhedonia, and with the potential to influence clinical outcomes and quality of life regardless of the severity of depressive symptoms. Despite its importance, the relationship between apathy and depression remains underrepresented in current research. This study aims to assess the prevalence of apathy in a sample of outpatients affected by MDD and to explore its clinical, cognitive, and functional correlates. Outpatients with MDD (n = 154) during a clinical stability phase have been assessed using the Apathy Evaluation Scale-Clinician version (AES-C), Dimensional Apathy Scale (I-DAS), MADRS, BDI-II, MMSE, PANSS, EQ-5D-3 L, and CGI-S. Patients were categorized into two groups according to the presence/absence of apathy (AES-C score ≥ 42). Groups comparison and a stepwise logistic regression were run to identify clinical differences between groups and the predictors of apathy. Apathy was detected in 48% of the sample. Patients with apathy scored higher on depression scales, had lower cognitive performance, more negative and general psychopathology, greater clinical severity, and reduced quality of life. Significant differences emerged in initiation and executive apathy. Logistic regression identified MADRS item 8 “inability to feel” and BDI-II item 12 “loss of interest” as the factors showing the strongest association with apathy. Apathy is a prevalent and clinically relevant feature in MDD, associated with greater psychopathology and functional impairment. Findings support the need to routinely assess apathy in clinical setting, even during symptomatic stability phases. Specific symptoms may serve as key markers for its identification. Apathy is a prevalent and clinically relevant feature in major depressive disorder (MDD). Patients with apathy reported greater clinical severity and poorer quality of life. “Inability to feel” and “loss of interest” are the strongest predictors of apathy in MDD. Apathy in MDD might be a bridging dimension between anhedonia and cognitive symptoms.

Authors

Institutions

Publication Details

Journal
Annals of General Psychiatry
Published
2026-02-24
DOI
https://doi.org/10.1186/s12991-026-00641-w
Primary Topic
Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Depression and apathy: examining an overlooked dimension

Alfonso Tortorella, Pasquale De Fazio, Alessia Scalzo, Marianna Rania et al.
Annals of General Psychiatry
Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
article

Depression and apathy: examining an overlooked dimension

Alfonso Tortorella, Pasquale De Fazio, Alessia Scalzo, Marianna Rania, Renato de Filippis, Cristina Segura-Garcia, Giulia Menculini, Elvira Anna Carbone, Emanuela Calabretta, Stefano Lodari
article en

Abstract

Apathy is a significant yet frequently overlooked aspect of Major Depressive Disorder (MDD), often confused with anhedonia, and with the potential to influence clinical outcomes and quality of life regardless of the severity of depressive symptoms. Despite its importance, the relationship between apathy and depression remains underrepresented in current research. This study aims to assess the prevalence of apathy in a sample of outpatients affected by MDD and to explore its clinical, cognitive, and functional correlates. Outpatients with MDD (n = 154) during a clinical stability phase have been assessed using the Apathy Evaluation Scale-Clinician version (AES-C), Dimensional Apathy Scale (I-DAS), MADRS, BDI-II, MMSE, PANSS, EQ-5D-3 L, and CGI-S. Patients were categorized into two groups according to the presence/absence of apathy (AES-C score ≥ 42). Groups comparison and a stepwise logistic regression were run to identify clinical differences between groups and the predictors of apathy. Apathy was detected in 48% of the sample. Patients with apathy scored higher on depression scales, had lower cognitive performance, more negative and general psychopathology, greater clinical severity, and reduced quality of life. Significant differences emerged in initiation and executive apathy. Logistic regression identified MADRS item 8 “inability to feel” and BDI-II item 12 “loss of interest” as the factors showing the strongest association with apathy. Apathy is a prevalent and clinically relevant feature in MDD, associated with greater psychopathology and functional impairment. Findings support the need to routinely assess apathy in clinical setting, even during symptomatic stability phases. Specific symptoms may serve as key markers for its identification. Apathy is a prevalent and clinically relevant feature in major depressive disorder (MDD). Patients with apathy reported greater clinical severity and poorer quality of life. “Inability to feel” and “loss of interest” are the strongest predictors of apathy in MDD. Apathy in MDD might be a bridging dimension between anhedonia and cognitive symptoms.

Annals of General Psychiatry
University of Perugia (IT), Magna Graecia University (IT), Dulbecco Telethon Institute (IT), Ospedale Cannizzaro (IT)
Openalex Percentile: Top 47%
Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.